ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1059

Perinatal and Early Life Risk Factors For Systemic Lupus Erythematosus In a National Cohort Of Women

Christine G. Parks, Aimee D'Aloisio and Dale Sandler, Epidemiology Branch, NIH/NIEHS, Research Triangle Park, NC

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Environmental factors and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Health Services II & III

Session Type: Abstract Submissions (ACR)

Background/Purpose: Growing evidence supports the role of perinatal and early life exposures in risk for chronic adult diseases. We examined perinatal and early life environmental risk factors for SLE in a national cohort of women ages 35-74 at enrollment in 2003-2009.

Methods: Questionnaire data were collected on maternal and perinatal factors and characteristics of longest childhood residence. Prevalent SLE cases (N=124; median age 54, interquartile range, IQR 47-60; diagnosis age 43, IQR 33-50) were identified based on self-reported diagnosis after age 17, and confirmed by current or past use of disease modifying anti-rheumatic drugs (DMARDs) for SLE. Non-cases were women who did not report SLE or discoid lupus (N=50,465; median age 55 years, IQR 50-61). Odds Ratios (OR) and 95% Confidence Intervals (CI) were estimated by logistic regression, adjusting for age and race/ethnicity.

Results: Most cases were non-Hispanic whites (69% vs. 84% non-cases), but cases were more likely to be African-American (19% vs. 9%; OR=2.4; 95%CI 1.5, 3.8) or Hispanic (9% vs. 5%; OR=2.2; 95%CI 1.2, 4.1). Low birth weight (<2500 grams) was associated with risk of SLE (vs. 3000-<3500 grams; OR=2.2, 95%CI 1.2, 3.9), with a significant inverse linear dose-effect for increasing birth weight based on data for 84 cases and 36,477 non-cases. Premature birth (>4 weeks vs. full-term) was also associated with SLE (OR=3.0; 95%CI 1.4, 6.5), but only 47 cases and 15,996 non-cases reported gestational age.  An association of SLE with young maternal age (<18 vs. 18-34 years) was not significant after adjusting for race/ethnicity (OR=1.7; 95%CI 0.71, 3.2), and no associations were seen for prenatal smoking exposure (maternal or household), having been breastfed, birth order, or sibling number.  SLE was associated with having a mother who worked on a farm during pregnancy (OR=1.7; 95%CI 1.1, 2.7). Considering longest childhood residence, SLE cases were more likely to have lived on a farm (OR= 1.6; 95%CI 1.0, 2.6) and reported pesticides were regularly (at least monthly) applied in and around the home (OR=2.3; 95%CI 1.3, 4.1). SLE was not associated with residential well water or childhood socioeconomic status (household education, income, food insecurity). 

Conclusion: Our observed association of premature birth with DMARD-treated SLE is consistent with other studies, but could not be separated from the effect of low birth weight. Findings on maternal farm work, childhood farm residence and household pesticide application require confirmation, but are supported by previous evidence on adult farming and pesticide exposures associated with systemic autoimmune diseases, including SLE.


Disclosure:

C. G. Parks,
None;

A. D’Aloisio,
None;

D. Sandler,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perinatal-and-early-life-risk-factors-for-systemic-lupus-erythematosus-in-a-national-cohort-of-women/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology